Abstract
The use of biological therapy has been linked with an increased risk of tuberculosis (TB) reactivation. The aim of this study was to present the follow-up results for isoniazid (INH) chemoprophylaxis in patients receiving different biological therapies. In this prospective observational study, patients with latent tuberculosis infection (LTBI) were given INH chemoprophylaxis between 2 and 9 months prior to the beginning of biological therapy. All patients were followed up monthly for any signs or symptoms of active TB or INH toxicity. A total of 221 patients, 122 females (55.2 %), with a mean age of 46.8 ± 11.3 years (16-74) were enrolled. LTBI was identified in 218 patients (98.7 %), all of whom received INH chemoprophylaxis. Seven patients (3.2 %) developed active tuberculosis, and 32 (17.2 %) patients developed intolerance or toxicity related to INH. Chemoprophylaxis with INH seems to be effective and safe for the prevention of most TB reactivation in individuals with LTBI, but toxicity must be monitored during follow-up.
References
Oct 16, 2002·Annals of the Rheumatic Diseases·D E FurstR Kurth
Mar 5, 2003·The Lancet Infectious Diseases·Michael A GardamDonald C Vinh
Aug 16, 2005·Annals of the Rheumatic Diseases·D Ponce de LeónC Sánchez-Schwartz
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul BrassardSamy Suissa
Nov 6, 2007·Journal of Korean Medical Science·Jong Wook YunWon-Jung Koh
Mar 6, 2008·Clinical Rheumatology·Ismail HantaAli Kocabas
Oct 22, 2009·Rheumatology International·Tulin CagatayZeki Kilicaslan
Dec 18, 2009·Journal of Leukocyte Biology·Paolo SfrisoAndrea Doria
Jul 27, 2010·Rheumatology International·Muhammad HaroonJoe Devlin
Nov 8, 2011·JAMA : the Journal of the American Medical Association·Carlos G GrijalvaJeffrey R Curtis
Apr 24, 2012·Annals of the Rheumatic Diseases·K L WinthropL J Herrinton
Mar 22, 2013·Archives of Medical Science : AMS·Jolanta Paluch-OleśMaria Majdan
Jun 4, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Xi XieJia Wang
Citations
Mar 12, 2016·International Journal of Mycobacteriology·Lingaraja Jena, Bhaskar C Harinath
May 27, 2017·Dermatologic Therapy·Andrea ContiGiovanni Pellacani
Mar 25, 2018·Pharmacoepidemiology and Drug Safety·Christopher PeaseGonzalo G Alvarez
Sep 1, 2018·International Journal of Rheumatic Diseases·Vineeta ShobhaK R Anupama
May 5, 2016·Zeitschrift für Rheumatologie·A Zink, K Albrecht
Jan 14, 2017·Microbiology Spectrum·Juan Carlos Cataño, Jaime Robledo